First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil

被引:76
作者
Palazzo, ICV
Araujo, MLC
Darini, ALC
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Ribeirao Preto, SP, Brazil
[2] Univ Estadual Paulista, Fac Ciencias Agr & Vet Jaboticabal, Sao Paulo, Brazil
关键词
D O I
10.1128/JCM.43.1.179-185.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Reduced susceptibility or resistance to vancomycin has been reported among clinical isolates of staphylococci in previous studies. In the present study we report on the isolation of four vancomycin-resistant staphylococcal strains from healthy carriers inside and outside the hospital environment. These carriers did not receive treatment with any antibiotic. All coagulase-negative staphylococcal strains showed variable levels of resistance to several antimicrobial agents, including oxacillin, and unstable resistance to vancomycin, with decreased vancomycin MICs (<4 mg/liter) after 10 days of passage in a nonselective medium. However, exposure of these revertants to vancomycin selected staphylococcal strains resistant to vancomycin at very high frequencies (10(-2) and 10(-3)). The vancomycin resistance in these staphylococcal strains was not mediated by the van gene. The cell wall of the staphylococcal strains studied became thickest after culture in medium containing vancomycin, and the differences in cell wall thickness were statistically significant (P < 0.001). Thus, the thickening of the cell wall in these staphylococcal strains may be an important contributor to vancomycin resistance.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 32 条
[1]
Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance [J].
Bignardi, GE ;
Woodford, N ;
Chapman, A ;
Johnson, AP ;
Speller, DCE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) :53-63
[2]
Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative [J].
Bobin-Dubreux, S ;
Reverdy, ME ;
Nervi, C ;
Rougier, M ;
Bolmström, A ;
Vandenesch, F ;
Etienne, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :349-352
[3]
Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates [J].
Boyle-Vavra, S ;
Berke, SK ;
Lee, JC ;
Daum, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :272-277
[4]
*CDCP, 2002, MMWR-MORBID MORTAL W, V26, P565
[5]
Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit:: Evidence of spread of Staphylococcus warneri [J].
Center, KJ ;
Reboli, AC ;
Hubler, R ;
Rodgers, GL ;
Long, SS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) :4660-4665
[6]
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P322
[7]
Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus [J].
Cui, L ;
Ma, XX ;
Sato, K ;
Okuma, K ;
Tenover, FC ;
Mamizuka, EM ;
Gemmell, CG ;
Kim, MN ;
Ploy, MC ;
El Solh, N ;
Ferraz, V ;
Hiramatsu, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :5-14
[8]
Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 [J].
Cui, LZ ;
Murakami, H ;
Kuwahara-Arai, K ;
Hanaki, H ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2276-2285
[9]
DUKTAMALEN S, 1995, J CLIN MICROBIOL, V33, P24
[10]
Overview of resistance in the 1990s [J].
File, TM .
CHEST, 1999, 115 (03) :3S-8S